Intensity Therapeutics (INTS) Proxy Filing summary

Executive summary

• Annual meeting scheduled for July 17, 2024, at 10:30 a.m. ET, to be held virtually.

• Shareholders are encouraged to review proxy materials and vote by July 16, 2024.

Voting matters and shareholder proposals

• Election of two Class I directors, Daniel A. Donovan and Thomas I. H. Dubin, for three-year terms expiring in 2027.

• Approval of the 2024 Employee Stock Purchase Plan.

• Ratification of EisnerAmper LLP as independent registered public accounting firm for fiscal year ending December 31, 2024.

• Board recommends voting in favor of all proposals.

Board of directors and corporate governance

• Board nominees for Class I director positions are Daniel A. Donovan and Thomas I. H. Dubin.